ASH 2010 Conference Coverage

Robotic inferior vena cava (IVC) thrombectomy successfully removes thrombus associated with kidney cancer

Inferior vena cava (IVC) thrombectomy is typically is performed via a large open incision, but recently the procedure was successfully performed robotically, using only seven small incisions.

Clinical scoring system suggests more precise colon cancer screening is possible

A clinical scoring system for colon cancer risk could help physicians determine which patients require colonoscopies and which could be adequately screened using less invasive methods.

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: A meta-analysis of Phase III randomized controlled trials

[OncoTargets and Therapy] This research compares the efficacy and safety of docetaxel and pemetrexed or docetaxel and vinca alkaloid for non-small-cell lung cancer.

Researchers identify tumor microenvironment of metastasis (TMEM) that allows breast cancer to metastasize

Using high-resolution imaging, scientists have gained a greater understanding of how a doorway in the blood vessel wall allows cancer cells to metastasize.

Race and institutional factors play important roles in pharmacogenomics trial participation

Researchers examined patient participation in the genomic analysis portion of clinical trials.

Research group looking to bring Cuba's lung cancer vaccine to the United States

As relations between the United States and Cuba normalize, groundbreaking lung cancer research and a vaccine may be early imports.

Patients with advanced cancer prefer open, effective communication

A majority of patients with advanced cancer preferred that their physicians be realistic about their future.

26 percent of senior oncology patients use alternative therapies

More than a quarter of senior oncology patients use complementary or alternative medicines (CAM).

Older, younger patients with metastatic pancreatic cancer have similar survival

Older patients metastatic pancreatic cancer are less likely to receive chemotherapy compared with younger patients with metastatic disease.

New tool uses drug spillover to match cancer patients with treatments

A new tool predicts what genetics are truly driving the cancer in any population of cells and helps the user choose the best kinase inhibitor to address the issue.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs